KALAMASU, Michigan (AB) – The first shipment of the Covit-19 vaccine for widespread use in the United States went to distribution centers across the country from Michigan on Sunday, with the first shots expected to be delivered to health workers next week and at nursing homes. Pfizer vaccine ships are operating at a critical juncture that has killed 1.6 million people in the largest vaccination effort in U.S. history and infected 71 million worldwide. Initially expected to deliver about 3 million doses, the vaccine provides a bright spot in the fight against the epidemic that has killed nearly 300,000 people, with health workers and nursing home residents likely to worsen over the holidays as epidemics, hospitals and deaths rise in the United States. Americans. The first shipments of the Pfizer vaccine will arrive at 145 distribution centers on Monday, with an additional 425 sites shipping carts on Tuesday, and the remaining 66 on Wednesday. The vaccine, developed jointly by German partner Bioendech, is based on the adult population of each state. The Pennsylvania-based healthcare company UPMC has selected key staff to run its facilities among first-round vaccine recipients, the doctor said. Graham Snyder, who headed the center’s vaccination task force. “It simply came to our notice then. I look forward to the moment we manage our first dose, ”Snyder said Saturday. “This is going to be a diabetic moment for us,” Snyder said. The UPMC estimates that half of its staff will be ready to receive the vaccine once it has been administered. The vaccine goes to hospitals and other sites where it can be stored at very low temperatures – below zero 94 degrees. Pfizer uses containers with dry ice and GPS-enabled sensors to ensure that each ship is cooler than the weather in Antarctica. Federal officials said all vaccine sites identified by states, such as local pharmacies, must be given the drug within three weeks. The 40-hospital Oshner Health System in Louisiana and Mississippi expects to receive more than 9,000 doses in the coming days, said Dr. Sandra Kemmerley, the hospital’s medical director. Employees who have approved the first round receive texts and emails on their initial injection, he said. “I would say there is excitement,” Kemmerley said Saturday. “The idea is that if they can be vaccinated and immunized they don’t have to be too scared to come to work.” This release will ensure that there is an adequate vaccine to provide people with the two doses needed for full protection against COVID. 19. That is, a few weeks later the government withholds the 3 million dose to give a second shot to those who were vaccinated in the first round. The Food and Drug Administration on Friday approved the vaccine for emergency use, which is very safe and has no major safety issues. Despite months of hard work by US regulators to assert the severity and independence of their review, they faced political pressure until the final stages. Concerns that a shot was fired quickly could undermine vaccination efforts in a country where some are skeptical about vaccines. The FDA chief said the agency’s decision was based on science, not politics, despite the White House threatening to expel him if the vaccine was not approved on Saturday. Speaking to Fox News on Sunday, Chief Scientific Adviser Dr. Monsieur Slavy said he was “deeply concerned” about the skepticism about the vaccine in some circles, Operation Warp Speed, a US initiative to promote vaccines. “Unfortunately, there was so much politics in the context of developing this vaccine, there is so much complete work and confusion between science and reality, and the perception that people think we’re cutting corners or something like that,” Slavy said. “Nothing like this has ever happened. I guarantee you that we follow science.” He called for the development of vaccines for several pharmaceutical companies, including Modern and AstraZeneca, “a significant achievement of the scientific, educational, industrial environment and the US government, working together.” Although the vaccine has been determined to be safe, regulators in the UK are investigating several severe allergic reactions. The FDA’s instructions tell suppliers not to give any of its products to people with severe allergic reactions. Another vaccine for moderna will be reviewed by a panel of experts next week and may soon be approved for general use. .
Source